Tuesday, November 18, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Venus Concept Inc Stock Price Drops After Direct Offering

Elaine Mendonca by Elaine Mendonca
February 23, 2024
in Breaking News
0
The Rise of Enterprise Business Intelligence Platforms: Transforming Operations in the Healthcare Sector
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Venus Concept, a leader in minimally invasive medical aesthetic and hair restoration technologies, has seen a drop in their stock price following a $1.2 million registered direct offering at $1.465 per share announced on February 23, 2024.

The stock price of Venus Concept Inc. (VERO) on NASDAQ has taken a hit, with after-hours trading showing an 8.60% decrease. The latest price stands at $1.12, reflecting a change of -8.17%.

In 2022, Venus Concept Inc. reported revenue of $99.50 million, marking a decrease from the previous year. Despite the fluctuating stock prices, the company remains committed to developing and delivering cutting-edge technologies to clients worldwide.

VERO Stock Plummets 24.73% on February 23, 2024

On February 23, 2024, VERO stock experienced a significant drop in its price performance. The stock opened at $1.37, which was $0.49 lower than its previous close. Throughout the trading day, VERO shares continued to decline, ending with a price decrease of $0.46. This represented a 24.73% drop in the stock’s value.

VERO Stock Faces Challenges with Declining Financial Performance in 2024

VERO stock had a challenging day on February 23, 2024, as the company’s financial performance took a hit compared to previous periods. According to data from CNN Money, VERO reported a total revenue of $99.50 million for the past year, which represented a 5.8% decrease compared to the previous year. Additionally, the total revenue for the most recent quarter was $17.62 million, showing a 12.25% decrease compared to the previous quarter.

The company’s net income also saw a significant decline, with a reported net loss of $43.70 million for the past year and a net loss of $9.07 million for the most recent quarter. This represented an 89.89% decrease in net income compared to the previous year and a 22.39% decrease compared to the previous quarter.

Earnings per share (EPS) for VERO also took a hit, with an EPS of -$9.94 for the past year and an EPS of -$1.64 for the most recent quarter. This represented a 56.8% decrease in EPS compared to the previous year and a 21.16% decrease compared to the previous quarter.

Overall, VERO’s stock performance on February 23, 2024, reflected the company’s declining financial performance over the past year and quarter. Investors may be concerned about the company’s ability to turn things around and improve its financial results in the future. It will be important for VERO to address the factors contributing to these declines and implement strategies to enhance its revenue and profitability moving forward.

Tags: VERO
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Fiscal (1)

Analyst Reaffirms Optimistic View on NICE with Market Outperform Rating

EEFT stock news

Financial Analyst Reaffirms Positive Outlook on Lantheus Holdings

Healthcare cloud based

Analysts Remain Bullish on Evolent Health Adjust Price Targets

Recommended

CoStar Stock

The Unstoppable Ascent of CoStar Group: A Deep Dive into Commercial Real Estate’s Data Powerhouse

3 months ago
Entertainment Markets and money (1)

Mark Wahlberg From Hollywood Success to Business Mogul

2 years ago
Finance_Budgeting (1)

Betsy Graseck Maintains Underweight Rating on PNC Financial Services Group with Revised Price Target

2 years ago
Broadcom Stock

Broadcom’s Strategic Shifts Earn Credit Rating Upgrades Amid AI Boom

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Red Cat Holdings: Record Growth Meets Market Disappointment

Major Investors Abandon Applovin Stock

Oramed’s Corporate Defense: A Biotech’s Battle for Autonomy

MKS Instruments Delivers Stellar Quarterly Performance

Annovis Bio Stock Surges on Promising Parkinson’s Trial Results

Kezar Life Sciences Initiates Major Overhaul Following Regulatory Setback

Trending

Halozyme Therapeutics Stock
Analysis

Halozyme Stock Gains Momentum on Dual Catalysts

by Robert Sasse
November 18, 2025
0

Halozyme Therapeutics is riding a wave of positive developments, with two significant announcements providing substantial momentum for...

Apple Stock

Apple’s Contradiction: Strong Product Sales Amid Investor Skepticism

November 18, 2025
PayPal Stock

PayPal Forges Major Expansion of European BNPL Financing Partnership

November 18, 2025
Red Cat Stock

Red Cat Holdings: Record Growth Meets Market Disappointment

November 18, 2025
Applovin Stock

Major Investors Abandon Applovin Stock

November 18, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Halozyme Stock Gains Momentum on Dual Catalysts
  • Apple’s Contradiction: Strong Product Sales Amid Investor Skepticism
  • PayPal Forges Major Expansion of European BNPL Financing Partnership

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com